SCHEMBL7693032

SCHEMBL7693032

O=C(NCC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1C=Cc1ccc(CN2CCCC2)cc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 8/20 0.49
CTSB P07858 5/20 0.49
CTSS P25774 2/20 0.48
CTSK P43235 2/20 0.48
CTSL P07711 2/20 0.47
ACE P12821 6/20 0.42
ACE2 Q9BYF1 3/20 0.42
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
KCNH2 Q12809 1/20 0.41
CCR2 P41597 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7688914 0.99 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696618 0.96 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7691329 0.93 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695419 0.93 CAPN1 (0.49) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695276 0.91 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7696627 0.91 CAPN1 (0.51) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693292 0.90 CAPN1 (0.46) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7695354 0.89 CAPN1 (0.46) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7693169 0.88 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL
SCHEMBL7697899 0.88 CAPN1 (0.53) CAPN1CTSBCTSSCTSKCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed